Molecular Characterization of Early Human T/NK and B-lymphoid Progenitor Cells in Umbilical Cord Blood
Overview
Authors
Affiliations
The early stages of human lymphopoiesis are poorly characterized. Here, we compared the lymphoid potential of a novel umbilical cord blood CD34(+)CD45RA(hi)CD7(+) hematopoietic progenitor cell (HPC) population with that of CD34(+)CD45RA(hi)Lin(-)CD10(+) HPCs, previously proposed as candidate common lymphoid progenitors. Limiting-dilution and clonal analysis, fetal thymic organ cultures, and culture onto Notch ligand Delta-like-1-expressing OP9 cells, showed that although CD34(+)CD45RA(hi)CD7(+) HPCs could generate cells of the 3 lymphoid lineages, their potential was skewed toward the T/natural killer (T/NK) lineages. In contrast, CD34(+)CD45RA(hi)Lin(-)CD10(+) HPCs predominantly exhibited a B-cell potential. Gene expression profiling with DNA microarrays confirmed that CD34(+)CD45RA(hi)CD7(+) HPCs selectively expressed T-lymphoid and NK lineage-committed genes while retaining expression of genes affiliated to the granulomonocytic lineage, whereas CD34(+)CD45RA(hi)Lin(-)CD10(+) HPCs displayed a typical pro-B-cell transcription profile and essentially lacked genes unrelated to the B lineage. In addition, both populations could be generated in vitro from CD34(+)CD45RA(int)CD7(-) and CD34(+)CD45RA(hi)Lin(-) HPCs with mixed lymphomyeloid potential, from which they emerged independently with different growth/differentiation factor requirements. These findings indicate that CD34(+)CD45RA(hi)CD7(+) and CD34(+)CD45RA(hi)Lin(-)CD10(+) HPCs correspond to multipotent early lymphoid progenitors polarized toward either the T/NK or B lineage, respectively.
Generation of autologous hematopoietic stem cell-derived T lymphocytes for cancer immunotherapy.
Maneechai K, Khopanlert W, Noiperm P, Udomsak P, Viboonjuntra P, Julamanee J Heliyon. 2024; 10(19):e38447.
PMID: 39398019 PMC: 11467635. DOI: 10.1016/j.heliyon.2024.e38447.
Bristol J, Nelson S, Ohashi M, Casco A, Hayes M, Ranheim E PLoS Pathog. 2024; 20(4):e1012132.
PMID: 38620028 PMC: 11045125. DOI: 10.1371/journal.ppat.1012132.
Gu J, Qian J, Cao X Front Oncol. 2024; 14:1272209.
PMID: 38529384 PMC: 10961394. DOI: 10.3389/fonc.2024.1272209.
Alhaj Hussen K, Chabaane E, Nelson E, Lekiashvili S, Diop S, Keita S iScience. 2023; 26(10):107890.
PMID: 37766969 PMC: 10520540. DOI: 10.1016/j.isci.2023.107890.
Circulating IRF8-expressing CD123CD127 lymphoid progenitors: key players in human hematopoiesis.
Liang K, Laurenti E, Taghon T Trends Immunol. 2023; 44(9):678-692.
PMID: 37591714 PMC: 7614993. DOI: 10.1016/j.it.2023.07.004.